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Original Article
Intra-individual comparison of PET/CT
with different body weight-adapted FDG
dosage regimens
Jan H Geismar1,2, Paul Stolzmann1,3,4, Bert-Ram Sah1,
Irene A Burger1,4, Burkhardt Seifert5, Gaspar Delso1,6,
Gustav K von Schulthess1, Patrick Veit-Haibach1,4 and
Lars Husmann1
Abstract
Background: 18F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/ computed tomography
(CT) imaging demands guidelines to safeguard sufficient image quality at low radiation exposure. Various FDG dose
regimes have been investigated; however, body weight-adapted dose regimens and related image quality (IQ) have not yet
been compared in the same patient.
Purpose: To investigate the relationship between FDG dosage and image quality in PET/CT in the same patient and
determine prerequisites for low dosage scanning.
Material and Methods: This study included 61 patients undergoing a clinically indicated PET/CT imaging study and
follow-up with a normal (NDS, 5 MBq/kg body weight [BW]) and low dosage scanning protocol (LDS, 4 MBq/kg BW),
respectively, using a Discovery VCT64 scanner. Two blinded and independent readers randomly assessed IQ of PETusing
a 5-point Likert scale and signal-to-noise ratio (SNR) of the liver.
Results: Body mass index (BMI) was significantly lower at LDS (P¼ 0.021) and represented a significant predictor of
SNR at both NDS (P< 0.001) and LDS (P¼ 0.005). NDS with a mean administered activity of 340 MBq resulted in
significantly higher IQ (P< 0.001) and SNR as compared with LDS with a mean of 264 MBq (F-value¼ 23.5, P< 0.001,
mixed model ANOVA adjusted for covariate BMI). Non-diagnostic IQ at LDS was associated with a BMI> 22 kg/m2.
Conclusion: FDG dosage significantly predicts IQ and SNR in PET/CT imaging as demonstrated in the same patient with
optimal IQ achieved at 5 MBq/kg BM. PET/CT imaging at 4 MBq/kg BW may only be recommended in patients with a
BMI 22 kg/m2 to maintain diagnostic IQ.
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Introduction
The increasing use of 18F-2-ﬂuoro-2-deoxy-D-glucose
(FDG) positron emission tomography (PET)/ com-
puted tomography (CT) imaging in cancer staging
revealed a rising demand for guidelines in order to
guarantee procedure safety and diagnostic quality (1).
Regarding dosage regimens, diﬀerent approaches exist
recommending either the administration of absolute (2)
or relative, i.e. body weight (BW)-adapted FDG dos-
ages (3). The latter approach factors the need for higher
1Division of Nuclear Medicine, University Hospital Zurich, Zurich,
Switzerland
2Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland
3Division of Neuroradiology, University Hospital Zurich, Zurich,
Switzerland
4Institute of Diagnostic and Interventional Radiology, University Hospital
Zurich, Zurich, Switzerland
5Division of Biostatistics, Institute of Social- and Preventive Medicine,
University of Zurich, Switzerland
6GE Healthcare, Waukesha, Wisconsin, USA
Corresponding author:
Paul Stolzmann, University Hospital Zurich, Raemistrasse 100, 8091
Zurich, Switzerland.
Email: paul.stolzmann@usz.ch
Acta Radiologica Open
4(2) 1–9
! The Foundation Acta Radiologica
2015
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2047981614560076
arr.sagepub.com
Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.
creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the
original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
 at UZH Hauptbibliothek / Zentralbibliothek Zuerich on April 1, 2015arr.sagepub.comDownloaded from 
administered activities in patients with an elevated body
mass index (BMI) (4). Diagnostic image quality (IQ) is
guaranteed and paralleled by a radiation burden which
is ‘‘as low as reasonably achievable’’ according to the
ALARA principle.
Many studies have not only explored into diﬀerent
acquisition parameters (5–8) but also compared the IQ
of a wide range of FDG dosages (9,10). All of the afore-
mentioned studies are, however, biased by the inter-
individual variability among diﬀerent patient cohorts.
Last but not least, there is limited agreement on the
relative FDG dosage that has to be administered in
BW-adapted FDG dosage regimens (3).
The aim of this study was to investigate into the
relationship between FDG dosage and IQ in PET/CT
in the same patient and to determine prerequisites for
low dosage scanning.
Material and Methods
This single center observational cohort study was
approved by the review board of our institution, and
informed consent was waived due to the retrospective
nature of the study.
Patients
Imaging studies obtained between November 2012 and
August 2013 were reviewed to identify patients who had
undergone PET/CT with normal dosage scanning
(NDS), i.e. FDG-dosage of 5 MBq/kg BW (n¼ 167)
and low dosage scanning (LDS), i.e. FDG-dosage of
4 MBq/kg BW (n¼ 86) during follow-up (time interval,
133 63days). Patients were included when neither
electronic patient chart (i.e. abnormal laboratory ﬁnd-
ings, ultrasound, magnetic resonance imaging) nor
PET/CT imaging (i.e. PET with NDS, low-dose CT
for attenuation correction, and/or additional contrast-
enhanced abdominal CT studies) indicated any evi-
dence of focal or diﬀuse hepatic disease (n¼ 73).
Patients were excluded when suﬀering from diabetes
mellitus (n¼ 11), incidental paravenous injections
(n¼ 0), or when follow-up PET/CT imaging with
LDS newly demonstrated hepatic disease (n¼ 1). The
ﬁnal sample size consisted of 61 patients (27 women;
mean age, 60 14 years; age range, 25–84 years; Fig. 1).
Patients suﬀered from head-and-neck (n¼ 15), breast
(n¼ 10), lung (n¼ 9), or gastrointestinal (n¼ 7), gyne-
cological (n¼ 3), urological cancer (n¼ 1), or melan-
oma (n¼ 7), lymphoma (n¼ 5), and sarcoma (n¼ 4).
PET/CT imaging
After 4 h of fasting prior to PET/CT, BW, height, and
glucose levels were measured. After the intravenous
injection of FDG, patients were resting for 60min.
Data were acquired on a Discovery VCT64 scanner
(GE Healthcare, Milwaukee, WI, USA) employing bis-
muth germanate (BGO) scintillators. The patient was in
supine position with arms overhead.
Low-dose CT was acquired with the following par-
ameters: tube voltage, 140 kVp; tube current time prod-
uct, 10–80 mAs/slice; pitch, 1.4; collimation,
64 0.625mm; rotation time, 0.5ms; and ﬁeld of view
(FOV), 50 cm; reconstructed slice thickness, 3.75mm;
increment, 3.0mm. PET data were acquired using the
three-dimensional (3D) mode with a ﬁxed scan dur-
ation of 2min per bed position. Emission data were
corrected for randoms, dead time, scatter, and attenu-
ation; reconstruction was performed using a standard
iterative ordered subset expectation maximization
(OSEM, 8 iterations, 16 subsets) 3D algorithm;
matrix size, 256 256.
Subjective IQ
Anonymized images were evaluated by two experienced
readers (with 10 and 4 years of experience). Both read-
ers blinded to patient data (i.e. glucose levels, reason of
referral, dosage regimens) independently evaluated all
studies in random order on a dedicated workstation
(Advantage Windows, version 4.6; GE Healthcare).
Subjective IQ of axial and coronal PET/CT was rated
on maximum intensity projection (MIP) of PET. Semi-
quantitative assessment was performed with a 5-point
Likert scale (9): score of 5, excellent IQ without any
apprehensible image noise and with completely homo-
genous PET signal in the liver; score of 4, good IQ but
locally non-uniform PET signal; score of 3, moderate IQ
with image noise leading to a globally non-uniform
signal reducing the conﬁdence in the diagnostic assess-
ment; score of 2, poor IQ with patchy signal interspaced
with reduced background activity mimicking focal hep-
atic disease; score of 1, deﬁcient IQ with massive signal
inhomogeneity considered inadequate for any diagnostic
use. Scores of 5 and 4 were considered valid for diagnos-
tic purposes, whereas scores of 1–3 were considered of
non-diagnostic quality. Exams were not repeated due to
the retrospective nature of evaluation.
Objective IQ
Objective IQ readout was performed 2 weeks after the
subjective quality ratings. Both readers blinded to
patient data and results of subjective IQ analyses inde-
pendently assessed the objective IQ. Mean activity and
corresponding standard deviation (SD) were measured
using electronic calipers. Spherical shaped volumes of
interest (VOI, 195 74mL; 51–470mL) were placed
within the liver. Maximum VOI volume and placement
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was conﬁrmed on 3D reformats (11). Signal and image
noise were deﬁned as the mean activity concentration
and corresponding standard deviation (SD), respect-
ively (12). Signal-to-noise ratio (SNR) was calculated
as the ratio of mean activity concentration to SD (10).
SUV was not used for objective IQ measurements to
avoid the eﬀect of normalization to BW as we used a
BW-adapted dose regimen.
Statistical analysis
Continuous variables were expressed as mean SD,
categorical variables as frequencies and percentages.
The Student’s t-test for related samples was used to
assess for any change in patient demographics.
To test for inter-reader agreement, measurements of
both readers were compared. Consensus reading was
appended in any case of disagreement. To test for
intra-reader agreement of subjective and objective IQ-
ratings, respectively, the ﬁrst author re-evaluated 20
randomly selected imaging studies 6 weeks after the
initial readout to avoid memory bias. Because of the
excellent inter-reader agreement, mean measurements
were taken for further analysis. The intra- and inter-
reader agreements regarding subjective and objective
IQ were analyzed by kappa-statistics and intra-class cor-
relation coeﬃcients (ICC), respectively (13).
Subjective IQ between NDS and LDS was compared
with using the Wilcoxon signed rank test. Diﬀerences in
objective IQ were assessed using the Student’s t-test for
related samples. Correlation between subjective IQ and
SNR was evaluated using the Spearman’s rank test.
A mixed model ANOVA was performed to assess
the dependency of SNR from FDG dosage before
and after adjustments for signiﬁcant covariates (i.e.
BMI as demonstrated during univariate testing) and
the patient as a random factor.
A P value of< 0.05 was considered statistically sig-
niﬁcant. Statistical analyses were performed using com-
mercially available software (IBM SPSS Statistics,
Fig. 1. Flowchart of the study design.
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Version 21.0. IBM Corp., Armonk, NY, USA).
Relationships of SNR and BMI at NDS and LDS
were evaluated using smooth functions with automatic
smoothing parameter selection using package mgcv for
R (14).
Results
Patients
Mean FDG activity and blood glucose levels at LDS
did not signiﬁcantly (both P> 0.05) diﬀer from those at
NDS. The mean BMI was signiﬁcantly (P< 0.05) lower
at LDS as compared with NDS (Table 1).
Subjective IQ reading
The intra-reader agreement was high (kappa¼ 0.84,
P< 0.001), inter-reader agreement was substantial
(kappa¼ 0.68, P¼ 0.002).
NDS resulted in excellent imaging quality in 40/61
patients (66%) and good IQ in 21/61 patients (34%,
Fig. 2). LDS resulted in an excellent IQ in 10/61
patients (16%), good IQ in 37/61 patients (61%), mod-
erate IQ in 13/61 patients (21%), poor IQ in 1/61
patients (2%). IQ was signiﬁcantly (P< 0.001) better
at NDS as compared with LDS. All of the studies
had diagnostic IQ at NDS, whereas a total of 14/
61studies (23%) at LDS demonstrated non-diagnostic
IQ (Fig. 3) with all of the latter occurring in patients
with a BMI> 22 kg/m2 (n¼ 29, 48%). In all patients
with BMI< 21.8 kg/m2, IQ was diagnostic at LDS
(Fig. 4).
Objective IQ
Both intra- and inter-reader agreement was excellent
regarding signal (both ICC¼ 0.99, P< 0.001) and
noise measurements (ICC¼ 0.95 and ICC¼ 0.90,
respectively, both P< 0.001).
There was a signiﬁcant (P< 0.001) correlation
between subjective IQ and SNR (rho¼ 0.32).
The mean signal was 7.1 1.4 kBq/mL (range, 4.0–
11.4 kBq/mL) at NDS and 5.7 1.2 kBq/mL (range,
3.1–8.8 kBq/mL) at LDS. Mean noise was 1.0 0.1
kBq/mL (range, 0.7–1.3 kBq/mL) at NDS and
0.9 0.2 kBq/mL (range, 0.5–1.2 kBq/mL) at LDS.
The mean SNR was 7.4 1.3 (range, 4.8–10.7) at
NDS and 6.8 1.1 (range, 4.1–9.6) at LDS (Fig. 5).
Signal and SNR were signiﬁcantly (both P< 0.001)
higher at NDS than at LDS. The correlation between
SNR and BMI was signiﬁcant at NDS (P< 0.001) and
LDS (P¼ 0.005).
Multivariate analyses demonstrated FDG dosage
regimens to signiﬁcantly predict SNR in PET/CT ima-
ging. The F-value for LDS vs. NDS increased after
adjustments for the signiﬁcant covariate of BMI was
performed (Table 2). When plotting the SNR to the
BMI, ﬂattening curves were noted with minimal turning
points at a BMI of 24.3 kg/m2 and 22.1 kg/m2 at NDS
and LDS, respectively (Fig. 6a and b).
Discussion
Our results demonstrate an optimal IQ at NDS with 5
MBq/kg BW. IQ at LDS was signiﬁcantly inferior but
maintained in smaller patients. This is underlined by
the fact that the BMI represents a signiﬁcant predictor
of IQ. Therefore, we suggest a cutoﬀ level of a BMI
smaller than 22 kg/m2 to use a LDS protocol with 4
MBq/kg BW. This similarly minimizes the number of
PET/CT studies with non-diagnostic IQ as well as the
radiation burden due a by 20% reduced administered
activity.
Although IQ has been demonstrated to behave
dosage dependent (10), to the best of our knowledge,
there are no studies which factored the high inter-sub-
ject variability of patients. In our study, the same
patient underwent both NDS and LDS for a valid com-
parison of diﬀerent dosage regimens.
Table 1. Patient and protocol parameters at normal (NDS) and low dosage scanning (LDS).
NDS LDS P value
Mean FDG activity administered (MBq) 340 24 (217–404) 264 33 (215–361) 0.001
Uptake time (min) 60.3 2.1 (56–69) 60.2 5.1 (38–79) 0.936
Mean blood glucose levels (mmol/L) 5.6 0.8 (4.2–7.7) 5.6 0.8 (3.9–7.9) 0.603
Body weight (kg) 65.2 9.8 (36–80) 64.2 9.7 (43–81) 0.013
Body height (cm) 169 8 (149–188) 169 8 (149–188) 1.000
BMI (kg/m2) 22.8 3.1 (16.0–32.1) 22.4 3.0 (17.4–32.5) 0.021
Time interval between scans 133 63 (18–198) n.a.
BMI, body mass index; FDG, 18F-2-fluoro-2-deoxy-D-glucose; n.a., not applicable.
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Fig. 3. A 55-year-old female patient suffering from gastric cancer having a BMI of 27 kg/m2 at NDS and 23 kg/m2 at LDS. (a) Axial PET
image, (b) PET coronal maximum intensity projection, and (c) fused PET/ CT image acquired at 5 MBq/kg BW (i.e. NDS) similarly
demonstrate diagnostic image quality. Corresponding (d) axial PET image, (e) coronal maximum intensity projection, and (f) fused PET/
CT image acquired at 4 MBq/kg BW (i.e. LDS) indicate non-uniform signal distribution that is most pronounced in the center and the
left hepatic lobe. Note focal signal inhomogeneity mimicking focal uptake (f, arrowhead) that may reduce the confidence in diagnostic
assessment.
Fig. 2. Bar chart demonstrating percentage distribution of image quality of positron emission tomography at normal (NDS) and low
dosage scanning (LDS). Note the significant (P< 0.001) decrease of image quality at LDS.
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Fig. 5. Box plots demonstrating the signal-to-noise ratio at NDS and LDS. Note the significant (P< 0.001) higher SNR with NDS as
compared with LDS.
Fig. 4. A 51-year-old female patient with the history of esophageal cancer and body mass index of 16 kg/m2 at NDS and 19 kg/m2 at
LDS. (a) Axial PET image, (b) coronal maximum intensity projection, and (c) fused PET/CT image acquired at 5 MBq/kg BW (i.e. NDS)
demonstrate excellent image quality. Corresponding (d) axial PET image, (e) coronal maximum intensity projection, and (f) fused PET/
CT image acquired at 4 MBq/kg BW (i.e. LDS) similarly demonstrate excellent image quality with completely homogenous PET signal in
the liver. Note that the diagnostic image quality is maintained with a BMI< 22 kg/m2.
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Subjective IQ was signiﬁcantly improved with NDS
as compared with LDS. This subjective IQ was signiﬁ-
cantly correlated with the objective IQ measurements.
This, however, may only hold true within certain ranges
since the human eye fails to appreciate reduced noise
levels beyond certain thresholds. Therefore, images
were evaluated by means of both objective and subject-
ive parameters.
A signiﬁcant decrease in BMI was noted between
NDS and LDS. Thus, statistical testing was corrected
for BMI. When plotting the SNR to BMI, ﬂattening of
curves were found at both NDS and LDS with minimal
Fig. 6. Scatter plots with smoothed functions (solid curves) and 95% confidence intervals (dashed curves) demonstrating the rela-
tionship between SNR and BMI at (a) NDS and (b) LDS. signal-to-noise ratio represents the difference from the mean signal to noise
and allows for a valid comparison of dependencies of SNR on BMI and thus optimal comparison among groups. Note the flattening
curves with increasing body mass indices and minimal turning points (dotted lines) at 24.3 kg/m2 at NDS and 22.1 kg/m2 at LDS.
Table 2. Multivariate models for the prediction of objective
image quality in PET.
F-value P value
(a) Model for signal-to-noise ratio
Normal vs. low dosage scanning 20.3 <0.001
(b) Model for signal-to-noise
adjusted for BMI
Normal vs. low dosage scanning 23.5 <0.001
Body mass index (kg/m2) 2.72 0.104
Higher F-value after adjustment for the covariate body mass index that
decreased significantly after high and prior to low dosage scanning.
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turning at 24 kg/m2 and 22 kg/m2, respectively. These
turning points represent the more than linear increased
attenuation of photon transmission in larger patients
(10). As a cutoﬀ, we suggest a BMI value of 22 kg/m2
to change from LDS to NDS on the bases of subjective
and objectives IQ.
The suggested cutoﬀ value represents a valid sugges-
tion for daily practice; however, several factors impact-
ing on PET IQ have to be considered (1,9,15,16).
Scanner performance may for instances be enhanced
by improved system geometry and novel non-photo-
multiplier based detectors (17) and time-of-ﬂight ima-
ging (7,18). Diﬀerent reconstruction parameters exist
and IQ may further be improved by applying modiﬁca-
tions to raw data or changing properties in the image
domain (19).
Finally, the noise equivalent count rate (NECR) rep-
resents a machine dependent quality measure of PET
raw data (20) that is strongly related to image noise and
SNR in the reconstructed image (21,22). This allows for
a comparison of IQ among PET machines, which is
facilitated when the NECR is plotted to activity con-
centrations (23). In detail, a distinct NECR is found at
diﬀerent activity concentrations when various machines
are used. If equal reconstruction parameters are
selected, the recommended activity cutoﬀ values for
the Discovery VCT machine may be corrected for
other target scanners accordingly (23).
We acknowledge the following limitations. We did
not adjust for potential longitudinal scanner variability
but routinely performed quality assurance and control
procedures (24). We did not consider increasing acqui-
sition times per bed position as a parameter for noise
reduction as examination times are valuable and cannot
be overly extended (25). Respiratory gating is known to
attenuate PET/CT imaging artifacts (26), improves IQ
which may translates into improved detection of lung
and liver lesions (27), but is not routinely performed.
Lesion detection or conspicuity was not assessed as
patients with liver lesions were excluded from our
study to overcome bias from confounding factors, e.g.
tumor progression and/or treatment. Therefore, the
risk of missing lesions at LDS could not be assessed
and has to be put in relation to beneﬁts of a reduced
risk for secondary cancer from radiation dose exposure.
No in-vivo dosimetry was performed to quantify the
patient’s radiation exposure at LDS and NDS. Last
but not least, our results are derived from a certain
scanner type only but we provide a theoretical
method for transferability by means of NECR to
other machine types.
In conclusion, administered FDG activity signiﬁ-
cantly predicts subjective IQ and SNR in PET/CT as
demonstrated in the same patient. Our data derived
from both subjective and objective measurements
both suggest BMI-based cutoﬀ values for choosing
FDG dosages to maintain diagnostic IQ. Given the
used imaging setting, an optimal IQ was achieved at 5
MBq/kg BW, whereas PET/CT imaging at 4 MBq/kg
BW can only be recommended in patients with a BMI
smaller than 22 kg/m2.
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